Suppression of pfkfb3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response

HIGHLIGHTS

• who: Hao Zeng from the Science and Technology Co [, ]Ltd. Hoechst , (KGA211-1) was from KeyGEN BioTECH (Nanjing, China). The information on primary antibodies applied in this study were listed in Supplementary Table, . Mice All animal procedures were performed conforming to the National Institutes of Health guidelines and approved by the Institutional Animal Care and Use Committee of China Pharmaceutical University. All mice used were male C Bl/6j mice obtained from GemPharmatech Co., Ltd (Nanjing, China). Mice were housed and fed under standard laboratory conditions with a, h light/dark cycle from , a.m. to , p . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.